FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

E Santoni-Rugiu

Research Profile

Disorders

Liver Neoplasms, Experimental

Chemicals & Drugs

Living Beings

Physiology

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
E Santoni-Rugiu; Michael Rugaard Jensen; Valentina M Factor; Snorri S Thorgeirsson
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
E Santoni-Rugiu; Michael Rugaard Jensen; Snorri S Thorgeirsson
Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
E Santoni-Rugiu; J A Silverman
Functional characterization of the rat mdr1b encoded P-glycoprotein: not all inducing agents are substrates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of E Santoni-Rugiu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: E Santoni-Rugiu; Michael Rugaard Jensen; Valentina M Factor; Snorri S Thorgeirsson
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
The American journal of pathology 1999;154(6):1693-700.
1998: E Santoni-Rugiu; Michael Rugaard Jensen; Snorri S Thorgeirsson
Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Cancer research 1998;58(1):123-34.
1997: E Santoni-Rugiu; J A Silverman
Functional characterization of the rat mdr1b encoded P-glycoprotein: not all inducing agents are substrates.
Carcinogenesis 1997;18(11):2255-63.
1997: Elizabeth A Conner; PJ Wirth; A Kiss; E Santoni-Rugiu; Snorri S Thorgeirsson
Growth inhibition and induction of apoptosis by HGF in transformed rat liver epithelial cells.
Biochemical and biophysical research communications 1997;236(2):396-401.
1997: Valentina M Factor; C Y Kao; E Santoni-Rugiu; JT Woitach; Michael Rugaard Jensen; Snorri S Thorgeirsson
Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
Cancer research 1997;57(11):2089-95.
1997: Snorri S Thorgeirsson; E Santoni-Rugiu
Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Mutation research 1997;376(1-2):221-34.
1997: Snorri S Thorgeirsson; E Santoni-Rugiu; CD Davis; Elizabeth G Snyderwine
Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1997;19():359-66.
1996: E Santoni-Rugiu; K H Preisegger; A Kiss; T Audolfsson; Goshi Shiota; Emmett V Schmidt; Snorri S Thorgeirsson
Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(18):9577-82.
1996: E Santoni-Rugiu; Péter Nagy; Michael Rugaard Jensen; Valentina M Factor; Snorri S Thorgeirsson
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
The American journal of pathology 1996;149(2):407-28.
1996: Snorri S Thorgeirsson; E Santoni-Rugiu
Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
British journal of clinical pharmacology 1996;42(1):43-52.
1996: Péter Nagy; Hanne Cathrine Bisgaard; E Santoni-Rugiu; Snorri S Thorgeirsson
In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene.
Hepatology (Baltimore, Md.) 1996;23(1):71-9.
1996: Hanne Cathrine Bisgaard; Péter Nagy; E Santoni-Rugiu; Snorri S Thorgeirsson
Proliferation, apoptosis, and induction of hepatic transcription factors are characteristics of the early response of biliary epithelial (oval) cells to chemical carcinogens.
Hepatology (Baltimore, Md.) 1996;23(1):62-70.